CVE-2023-37411: IBM Aspera Faspex cross-site scripting
Vulnerability summary
CVE-2023-37411 is a medium (CVSS 5.4) vulnerability in ibm aspera_faspex. EPSS estimates a 0.25% chance of exploitation in the next 30 days, higher than 16% of scored vulnerabilities.
Not severe (CVSS 4.8, network access); no exploitation reported by the 5 checked sources
Source freshness unavailable
How is this decided?Timeline
- 28-05-2024PublishedVulnerability first disclosed.
- 02-08-2024Last modifiedVulnerability information updated.
Description
IBM Aspera Faspex 5.0.0 through 5.0.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 260139.
CVSS metrics
2 scores · 2 sources · 1 version- CVE.orgCNA4.8MediumCVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:NDiffers
EPSS trend
Probability
0.25%
Chance of exploitation in the next 30 days
Percentile
16%
Versus all other CVEs
30-day change
No change 0.00 pp
From 0.25% on 11-10-2026
Known exploited
Compare KEV catalogsNot in the CISA KEV catalog.
Not in the ENISA CNW catalog.
Not in the CIRCL catalog.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Known conditions: network-reachable, administrative account, user interaction (CVSS vector). Other conditions: not stated in public data.
Ibm1 product
- aspera_faspex≥ 5.0.0, ≤ 5.0.6
1 vendor · 1 product
References
2 links- www.ibm.com/support/pages/node/7154977Vendor Advisory